Page last updated: 2024-09-05

deferasirox and Chemical and Drug Induced Liver Injury, Chronic

deferasirox has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brook, R; Fraser, J; He, T; Lewis, D1

Other Studies

1 other study(ies) available for deferasirox and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male.
    BMJ case reports, 2020, Jul-09, Volume: 13, Issue:7

    Topics: Adult; beta-Thalassemia; Chemical and Drug Induced Liver Injury, Chronic; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Male

2020